Enrollment Complete in Cerapedics’ Bone Graft Study

Cerapedics announced the completion of enrollment for the ASPIRE study, a pivotal FDA Investigational Device Exemption study, evaluating the safety and efficacy of P-15L Bone Graft for use in transforaminal lumbar interbody fusion (TLIF) surgery to treat degenerative disc disease.

P-15L Peptide Enhanced Bone Graft, which has been granted...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us